Publication:
Determination of DNA damage by alkaline halo and comet assay in patients under sevoflurane anesthesia

dc.contributor.authorsKadioglu, E.; Sardas, S.; Erturk, S.; Ozatamer, O.; Karakaya, A. E.
dc.date.accessioned2022-03-12T17:46:53Z
dc.date.accessioned2026-01-10T21:17:27Z
dc.date.available2022-03-12T17:46:53Z
dc.date.issued2009
dc.description.abstractIn this study, we report data on the possible genotoxic effect of inhalation anesthetic sevoflurane (SVF) by comparing two techniques, comet and alkaline halo assay, in peripheral blood lymphocytes (PBL) of patients before, during, and after anesthesia and in controls. DNA single strand breaks were detected in PBL of malignant breast cancer diagnosed patients (stage II-III), who were undergoing mastectomy. Blood samples were taken before the induction of anesthesia, at 120 min of SVF anesthesia, and on the postoperative fifth day. The nuclear spreading factor (NSF) for each cell was assessed by alkaline halo assay, and the total comet score (TCS) was evaluated by comet assay. A statistically significant increase (P < 0.0001) was observed in the mean NSF at 120 min of anesthesia (38.24 +/- 14.14) as compared with samples before anesthesia (12.33 +/- 6.14), and the mean NSF was significantly decreased after the postoperative fifth day (17.89 +/- 9.44). Similar results were obtained by the comet assay with significant increase (P < 0.0001) in DNA damage at 120 min of anesthesia (79.66 +/- 15.28) as compared with samples before anesthesia (36.30 +/- 11.39). The DNA damage was almost with the preoperative damage rates after the fifth day of anesthesia (43.40 +/- 12.19). In conclusion, the study points out a reversible genotoxic effect of SVF and the similar DNA damage levels obtained by comet and alkaline halo assay indicate that although halo assay has a completely different principle, it can conveniently be utilized for the assessment of DNA single strand breakage in individual mammalian cells with its experimental advantages. Toxicology and Industrial Health 2009; 25: 205-212.
dc.identifier.doi10.1177/0748233709106445
dc.identifier.eissn1477-0393
dc.identifier.issn0748-2337
dc.identifier.pubmed19482915
dc.identifier.urihttps://hdl.handle.net/11424/229596
dc.identifier.wosWOS:000267633500008
dc.language.isoeng
dc.publisherSAGE PUBLICATIONS INC
dc.relation.ispartofTOXICOLOGY AND INDUSTRIAL HEALTH
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectalkaline halo assay
dc.subjectcomet assay
dc.subjectDNA damage
dc.subjectsevoflurane anesthesia
dc.subjectsingle strand breaks
dc.subjectOPERATING-ROOM PERSONNEL
dc.subjectSISTER-CHROMATID EXCHANGES
dc.subjectBREAST-CANCER PATIENTS
dc.subjectSINGLE-STRAND BREAKS
dc.subjectHUMAN-LYMPHOCYTES
dc.subjectIN-VITRO
dc.subjectPERIPHERAL LYMPHOCYTES
dc.subjectGENOMIC DNA
dc.subjectCELLS
dc.subjectISOFLURANE
dc.titleDetermination of DNA damage by alkaline halo and comet assay in patients under sevoflurane anesthesia
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage212
oaire.citation.issue3
oaire.citation.startPage205
oaire.citation.titleTOXICOLOGY AND INDUSTRIAL HEALTH
oaire.citation.volume25

Files